"At current sp of .077 and a mc of less than $25m, why would any major pharma pay millions for anything associated with PAA...," (?)
Other pharmas.
"I don't see another company listed on ASX with so much going for it at such a low MC, so one needs to look at why Delays, expected"
Yes, it's very frustrating, but at least the trials are on, and unlike 9 years or even a couple of years ago, we have the tablet that seems not to be causing problems. A bit more patience. I know, I know, but after all this waiting, why give up now?
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-1336
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.1M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 22.0¢ | $89.24K | 403.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 142257 | 3 |
View Market Depth
| Last trade - 15.52pm 17/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |